Gutzwiller JP, Drewe J, Gke B, Schmidt H, Rohrer B, Lareida J, et al
Cooling was considered complete when the glass bead stabilized into spending specific amounts of time in each well, such as 20% of its time in the metastable one and 80% in the stable one
Whilst the research into GLP-1 receptor agonists and Parkinson's disease is promising, it remains in relatively early stages, and robust evidence from large-scale trials is needed before these drugs can be recommended for neuroprotection or symptom management in Parkinson's disease
Comparable effects of nicotine in smokers and nonsmokers on a prospective memory task
PMID: 29099763
Injectable GLP-1s may be better for those with severe reflux, gastroparesis risk, or inability to follow strict oral dosing routines, because injectables provide steadier medication exposure and may cause fewer day-to-day gastrointestinal fluctuations